Sequence (formerly Alloy) positions itself as a clinical weight care program that combines medication with ongoing support. They emphasize their expertise in navigating insurance coverage for GLP-1 medications.
The platform offers both brand-name medications (through insurance) and compounded options for cash-pay patients. Their care team approach includes physicians, care coordinators, and ongoing monitoring.
Insurance Navigation
Dedicated support for prior authorizations and appeals
Clinical Care Team
Physicians, nurses, and care coordinators
Ongoing Monitoring
Regular check-ins and progress tracking
Messaging Support
Direct access to your care team
Membership Fee
$99/mo
Includes care team access and insurance navigation
Compounded Medication
$199-$399/mo
If not using insurance for brand-name
Insurance Benefit: If your insurance covers GLP-1 medications, you'll pay the membership fee plus your plan's copay/coinsurance for medication. Sequence handles prior authorizations.
Wegovy (Semaglutide)
FDA-approved, insurance coverage available
Zepbound (Tirzepatide)
FDA-approved, insurance coverage available
Compounded Semaglutide
Cash-pay option for uninsured patients
Compounded Tirzepatide
Cash-pay option for uninsured patients
Online Assessment
Complete health questionnaire and insurance info
Insurance Verification
Team checks your coverage for GLP-1 medications
Physician Consultation
Video visit with obesity medicine specialist
Prior Authorization
Sequence handles PA submission and appeals if needed
1-3 Weeks
With insurance PA
3-5 Days
Compounded option
Specialty
Pharmacy network
- Expert insurance navigation and PA support
- Clinical care team with obesity expertise
- Both brand-name and compounded options
- Ongoing monitoring and support
- Monthly membership fee adds to total cost
- Insurance process can take several weeks
- Not available in all states yet
- Pricing structure can be confusing
"They got my Wegovy approved after my own doctor couldn't. The insurance navigation team knows exactly what to say in the prior auth. Worth the membership fee."
- Christine M.
"Good clinical care but the wait for insurance approval was frustrating. Ended up starting with compounded while waiting for brand-name approval."
- David K.
"The care team is responsive and knowledgeable. My insurance denied me twice but Sequence appealed and won. Now paying just my copay for Zepbound."
- Amanda R.
Sequence earns 4 out of 5 stars for their expertise in helping patients access GLP-1 medications through insurance. Their prior authorization and appeals process is more sophisticated than most competitors.
The monthly membership fee adds cost, but for patients with insurance coverage, the savings on brand-name medication can far outweigh this expense. The clinical care team approach also provides better ongoing support than basic telehealth providers.
Best for: Patients with insurance who want expert help navigating coverage for brand-name GLP-1 medications.
Not ideal for: Cash-pay patients seeking the lowest out-of-pocket costs for compounded medications.